Illumina Inc (ILMN.O)
ILMN.O on Nasdaq
313.10USD
19 Oct 2018
313.10USD
19 Oct 2018
Change (% chg)
$-8.35 (-2.60%)
$-8.35 (-2.60%)
Prev Close
$321.45
$321.45
Open
$324.00
$324.00
Day's High
$328.43
$328.43
Day's Low
$312.71
$312.71
Volume
1,482,926
1,482,926
Avg. Vol
955,540
955,540
52-wk High
$372.61
$372.61
52-wk Low
$198.21
$198.21
About
Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of... (more)
Overall
| Beta: | 0.95 |
| Market Cap(Mil.): | $47,905.83 |
| Shares Outstanding(Mil.): | 147.00 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ILMN.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 60.44 | 47.38 | 32.14 |
| EPS (TTM): | 5.39 | -- | -- |
| ROI: | 17.96 | 8.41 | 12.83 |
| ROE: | 26.72 | 11.97 | 14.95 |
BRIEF-Illumina Acquires Edico Genome To Accelerate Genomic Data Analysis
* ILLUMINA ACQUIRES EDICO GENOME TO ACCELERATE GENOMIC DATA ANALYSIS Source text for Eikon: Further company coverage:
BRIEF-Caredx Inc Enters Into A License And Commercialization Agreement With Illumina
* CAREDX INC - ON MAY 4, 2018, CO ENTERED INTO A LICENSE AND COMMERCIALIZATION AGREEMENT WITH ILLUMINA, INC - SEC FILING
BRIEF-Illumina Inc GAAP Earnings Per Share $1.41
* ILLUMINA REPORTS FINANCIAL RESULTS FOR FIRST QUARTER OF FISCAL YEAR 2018
Competitors
| Price | Chg | |
|---|---|---|
| Agilent Technologies Inc (A.N) | $64.47 | -1.28 |
| Roche Holding Ltd. (ROG.S) | CHF244.95 | +6.40 |
| Roche Holding Ltd. (RO.S) | CHF245.20 | +5.80 |
| Pacific Biosciences of California (PACB.OQ) | $4.38 | -0.13 |
| Qiagen NV (QGEN.N) | $35.91 | +0.46 |
| Thermo Fisher Scientific Inc. (TMO.N) | $227.15 | -2.56 |
Estimates